Senti Biosciences, Inc. financial data

Symbol
SNTI on Nasdaq
Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 337% % -28%
Debt-to-equity 187% % 87%
Return On Equity -198% % 27%
Return On Assets -63% % 53%
Operating Margin -27288% % -1781%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26,290,838 shares 473%
Common Stock, Shares, Outstanding 26,290,838 shares 473%
Entity Public Float $10,800,000 USD -54%
Common Stock, Value, Issued $3,000 USD 200%
Weighted Average Number of Shares Outstanding, Basic 26,228,274 shares 473%
Weighted Average Number of Shares Outstanding, Diluted 26,228,274 shares 473%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $0 USD -100%
Revenue from Contract with Customer, Excluding Assessed Tax $0 USD -100%
Research and Development Expense $37,597,000 USD 5.3%
General and Administrative Expense $28,400,000 USD 2.9%
Operating Income (Loss) $66,310,000 USD -4.3%
Nonoperating Income (Expense) $18,729,000 USD 91%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $47,581,000 USD 61%
Earnings Per Share, Basic -3 USD/shares 83%
Earnings Per Share, Diluted -3 USD/shares 83%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $12,243,000 USD 17%
Other Assets, Current $0 USD -100%
Assets, Current $18,158,000 USD 4.5%
Property, Plant and Equipment, Net $18,691,000 USD -16%
Operating Lease, Right-of-Use Asset $12,262,000 USD -15%
Other Assets, Noncurrent $34,000 USD -61%
Assets $52,685,000 USD -8.7%
Accounts Payable, Current $1,771,000 USD 123%
Employee-related Liabilities, Current $2,121,000 USD 35%
Liabilities, Current $12,027,000 USD 33%
Operating Lease, Liability, Noncurrent $24,968,000 USD -17%
Other Liabilities, Noncurrent $7,569,000 USD 198%
Liabilities $44,564,000 USD 6.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 USD -100%
Retained Earnings (Accumulated Deficit) $344,105,000 USD -16%
Stockholders' Equity Attributable to Parent $8,121,000 USD -49%
Liabilities and Equity $52,685,000 USD -8.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $14,050,000 USD -20%
Net Cash Provided by (Used in) Financing Activities $414,000 USD
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 26,290,838 shares 473%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $14,464,000 USD -24%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15,783,000 USD 12%
Deferred Tax Assets, Valuation Allowance $81,708,000 USD 33%
Deferred Tax Assets, Gross $85,407,000 USD 32%
Operating Lease, Liability $30,121,000 USD -13%
Depreciation $926,000 USD -5.9%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $47,581,000 USD 33%
Lessee, Operating Lease, Liability, to be Paid $39,762,000 USD -16%
Property, Plant and Equipment, Gross $30,855,000 USD 0.03%
Operating Lease, Liability, Current $5,153,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,769,000 USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year One $7,712,000 USD 3.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9,641,000 USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Three $4,855,000 USD -16%
Deferred Tax Assets, Operating Loss Carryforwards $50,961,000 USD 52%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $2,376,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid, Year Four $5,000,000 USD 3%
Additional Paid in Capital $352,223,000 USD 13%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $4,886,000 USD -9.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%